References
Drug and Therapeutics Bulletin (2016) QT interval and drug therapy. BMJ 353:i2732. https://doi.org/10.1136/bmj.i273
Howard PA (2013) Azithromycin-induced proarrhythmia and cardiovascular death. Ann Pharmacother 47:1547–1551
Schächtele S, Tümena T, Gaßmann KG et al (2016) Co-prescription of QT-interval prolonging drugs: an analysis in a large cohort of geriatric patients. PLoS One 11:e0155649
Tay KY, Ewald MB, Bourgeois FT (2014) Use of QT-prolonging medications in US emergency departments, 1995–2009. Pharmacoepidemiol Drug Saf 23:9–17
Varallo FR, Planeta CS, Mastroianni PC (2017) Effectiveness of pharmacovigilance: multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff. Clinics (Sao Paulo) 72:51–57. https://doi.org/10.6061/clinics/2017(01)09
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of human and animal rights
No animal was used in this study.
Informed consent
The patients signed a written informed consent in which she approved the publication.
Rights and permissions
About this article
Cite this article
Damanti, S., Brignolo-Ottolini, B., Cesari, M. et al. Apparently trivial but serious mistakes: the underestimated risk of a QT prolongation. Aging Clin Exp Res 30, 1247–1249 (2018). https://doi.org/10.1007/s40520-018-0900-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-018-0900-6